181 related articles for article (PubMed ID: 33167799)
1. Comprehensive Analysis of the Expression and Prognosis for MCMs in Human Gastric Cancer.
Guo F; Kong WN; Feng YC; Lv J; Zhao G; Wu HL; Ai L; Zhou X; Cai XL; Sun W; Ma XM
Technol Cancer Res Treat; 2020; 19():1533033820970688. PubMed ID: 33167799
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
[TBL] [Abstract][Full Text] [Related]
3. Multiomics profiling of the expression and prognosis of MCMs in endometrial carcinoma.
Lan H; Yuan J; Chen X; Liu C; Guo X; Wang X; Song J; Cao K; Xiao S
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34859821
[TBL] [Abstract][Full Text] [Related]
4. Expression Profile and Prognostic Values of Mini-Chromosome Maintenance Families (MCMs) in Breast Cancer.
Cheng L; Tan Z; Huang Z; Pan Y; Zhang W; Wang J
Med Sci Monit; 2020 Aug; 26():e923673. PubMed ID: 32830194
[TBL] [Abstract][Full Text] [Related]
5. Identification of mini-chromosome maintenance 8 as a potential prognostic marker and its effects on proliferation and apoptosis in gastric cancer.
Huang B; Lin M; Lu L; Chen W; Tan J; Zhao J; Cao Z; Zhu X; Lin J
J Cell Mol Med; 2020 Dec; 24(24):14415-14425. PubMed ID: 33155430
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of minichromosome maintenance mRNA expression in human lung adenocarcinoma.
Li S; Jiang Z; Li Y; Xu Y
Oncol Rep; 2019 Dec; 42(6):2279-2292. PubMed ID: 31545501
[TBL] [Abstract][Full Text] [Related]
7. The Expression and Prognostic Roles of MCMs in Pancreatic Cancer.
Peng YP; Zhu Y; Yin LD; Zhang JJ; Guo S; Fu Y; Miao Y; Wei JS
PLoS One; 2016; 11(10):e0164150. PubMed ID: 27695057
[TBL] [Abstract][Full Text] [Related]
8. MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma.
Yang S; Yuan Y; Ren W; Wang H; Zhao Z; Zhao H; Zhao Q; Chen X; Jiang X; Zhang L
Front Oncol; 2022; 12():1004324. PubMed ID: 36465369
[TBL] [Abstract][Full Text] [Related]
9. Identification of the Roles of Chromobox Family Members in Gastric Cancer: A Study Based on Multiple Datasets.
Chen ZY; Sun SX; Zhu SX; Bu J
Biomed Res Int; 2020; 2020():5306509. PubMed ID: 33344640
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of the expression of SLC30A family genes and prognosis in human gastric cancer.
Guo Y; He Y
Sci Rep; 2020 Oct; 10(1):18352. PubMed ID: 33110097
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic value of
Wang MQ; Yin QY; Chen YR; Zhu SL
Future Oncol; 2021 Dec; 17(35):4907-4923. PubMed ID: 34751593
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide investigation of the clinical significance and prospective molecular mechanism of minichromosome maintenance protein family genes in patients with Lung Adenocarcinoma.
Liu K; Kang M; Liao X; Wang R
PLoS One; 2019; 14(7):e0219467. PubMed ID: 31323040
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of MT Family Isoforms as Potential Biomarker for Predicting Progression and Prognosis in Gastric Cancer.
Tong M; Lu W; Liu H; Wu J; Jiang M; Wang X; Hao J; Fan D
Biomed Res Int; 2019; 2019():2957821. PubMed ID: 31380415
[TBL] [Abstract][Full Text] [Related]
14. The Alterations and Potential Roles of MCMs in Breast Cancer.
Liu X; Liu Y; Wang Q; Song S; Feng L; Shi C
J Oncol; 2021; 2021():7928937. PubMed ID: 34475953
[TBL] [Abstract][Full Text] [Related]
15. MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression.
Liu Z; Li J; Chen J; Shan Q; Dai H; Xie H; Zhou L; Xu X; Zheng S
BMC Cancer; 2018 Feb; 18(1):200. PubMed ID: 29463213
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.
Liu J; Liu Z; Zhang X; Gong T; Yao D
BMC Cancer; 2019 Mar; 19(1):227. PubMed ID: 30866865
[TBL] [Abstract][Full Text] [Related]
17. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.
He XY; Zhao J; Chen ZQ; Jin R; Liu CY
Med Sci Monit; 2018 Apr; 24():2244-2251. PubMed ID: 29654694
[TBL] [Abstract][Full Text] [Related]
18. FLAD1 is up-regulated in Gastric Cancer and is a potential prediction of prognosis.
Hu P; Pan Y; Wang C; Zhang W; Huang H; Wang J; Zhang N
Int J Med Sci; 2020; 17(12):1763-1772. PubMed ID: 32714079
[No Abstract] [Full Text] [Related]
19. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
20. Potential Prospective Biomarkers for Non-small Cell Lung Cancer: Mini-Chromosome Maintenance Proteins.
Huang C; Lei C; Pan B; Fang S; Chen Y; Cao W; Liu L
Front Genet; 2021; 12():587017. PubMed ID: 33936158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
